stooocks.com

Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.

abrdn Healthcare Investors

United States · NYSE: HQH · Market cap: · P/E: · P/S:

It is a closed-end fund that invests in healthcare company stocks for long-term capital appreciation.

abrdn Healthcare Investors is a closed-end fund. That means it is a pool of money raised from investors and listed on the New York Stock Exchange, where its shares trade throughout the day like a regular stock. The fund's job is simple to describe: it takes that pool of money and buys shares of healthcare companies, aiming to grow the money over the long run.

The fund's portfolio is spread across the healthcare world — drugmakers, medical device makers, biotech firms, and healthcare services companies. The idea is that healthcare spending tends to hold up reasonably well regardless of what the wider economy is doing, and that a professional manager picking stocks across the sector can do better than an investor buying a handful of names alone. Investors buy shares because they want exposure to healthcare without researching individual companies themselves. This is a closed-end fund, not an open-end mutual fund, and the distinction matters. The fund raised a fixed pool of money and generally does not sell new shares or redeem old ones on demand. Instead, its shares trade on the exchange, and their price can drift above or below the value of the underlying holdings. When the shares trade at a discount, buying them can be a way to get the portfolio for less than its parts are worth — and that discount can be a source of drama in itself. The fund sits in a crowded field. It competes for investor dollars against other healthcare-focused funds and against simply buying a healthcare index fund, which typically charges very little. The manager earns a fee based on assets, so the fund's size matters to the manager as much as its performance does to shareholders. Like any actively managed fund, its results depend heavily on whether its stock picks beat the sector — and healthcare is a sector where a single drug trial result or regulatory decision can move a stock violently.


The fund has also been through a rebranding: it was formerly known as Tekla Healthcare Investors, reflecting its long history under the Tekla name before coming under the abrdn banner. For an investor, the practical takeaway is straightforward: this is a way to own a professionally managed basket of healthcare stocks, with the usual trade-offs of active management — the potential for outperformance, the drag of fees, and the quirky price behavior that comes with a closed-end structure.

Saved answer · last researched 15 Nov 2026